Changes in mood and mental health are frequently associated with pro-inflammatory cytokines that trigger imbalances in certain neurotransmitters. Avipaxin supports normal brain function by utilizing acetylcholine and the cholinergic anti-inflammatory pathway to decrease elevated pro-inflammatory cytokine levels. Decreases Pro-inflammatory cytokines Normalizes cytokine-induced neurotransmitter imbalances Supports acetylcholine levels Improves mood, sleep quality, memory, and mental clarity.
Avipaxin contains Huperzine A, which is a potent inhibitor of acetylcholinesterase, the enzyme that metabolizes acetylcholine.
Blocking acetylcholinesterase increases circulating levels of acetylcholine. Avipaxin also contains -Glyceryl Phosphoryl Choline ( -GPC) and Acetyl-L-Carnitine. These ingredients supply choline and acetyl groups, respectively, for acetylcholine synthesis.
Cytokines released upon immune challenge activate the vagalnerve, resulting in increased cortisol levels via the Hypothalmic- Pituitary-Adrenal axis. Vagal pathways from the brain secrete acetylcholine, which binds to activated immune cells and down-regulates those cells’ pro-inflammatory cytokine production. Avipaxin supports acetylcholine levels, leading to a down-regulation of pro-inflammatory cytokines and a subsequent normalization of neurotransmitter concentrations.